NEW YORK (GenomeWeb News) – Helicos BioSciences this week named Stephen Hall as its new CFO. Hall most recently served as CFO of TriPath Imaging, a publicly traded cancer diagnostics firm that was acquired by Becton Dickinson in December 2006.
He is a certified public accountant, and started his career at Peat, Marwick, Mitchell & Co. in Chicago. Hall has an AB from Harvard College and an MBA from Stanford University’s Graduate School of Business.
According to a filing with the US Securities and Exchange Commission this week, Hall will receive an initial base salary of $278,000 and will receive an option to acquire 150,000 shares of Helicos’ common stock.
Hall replaces former CFO Louise Mawhinney, who resigned in March.
Cellectricon, a Swedish manufacturer of high-throughput drug screening systems, has appointed Jonas Ohlsson as its new CEO. He formerly served as CEO of Mentice AB, and he previously held executive management positions at PE Applied Biosystems, Kovalent AB, and AstraZeneca.
Cellectricon also said that its former acting CEO, Mattias Karlsson, has been appointed chief technology officer of the firm.
454 Life Sciences founder Jonathan Rothberg has founded Ion Torrent Systems, a startup company with locations in Guilford, Conn., and San Francisco. He is also the founder of Clarifi, CuraGen, and the Rothberg Institute for Childhood Diseases, and the co-founder and chairman of RainDance Technologies. Rothberg holds MS, MPhil, and PhD degrees in biology from Yale University and a BS in chemical engineering with an option in biomedical engineering from Carnegie Mellon University.
BioNanomatrix has appointed biophysicist Paul Selvin to its scientific advisory board, the firm said this week. Selvin is a professor of physics and biophysics at the University of Illinois at Urbana-Champaign. He is the inventor of a nanoimaging technique called Fluorescence Imaging with One Nanometer Accuracy.
Two researchers at The Scripps Research Institute who focus on genetics and molecular biology are among the 72 new members and 18 foreign associates elected this week to the National Academy of Sciences. Bruce Beutler, chair of the department of genetics at Scripps Research, and Peter Wright, chair of the department of molecular biology, were both elected to NAS.
The California Healthcare Institute said this week that it has elected Daniel O’Day and Michael Onuscheck to its board of directors.
O’Day is currently president and CEO at Roche Molecular Diagnostics in Pleasanton, Calif. Onuscheck is president of the neuromodulation division at Boston Scientific.
CHI is a non-profit public-policy research organization representing California’s academic institutions, and biotechnology, medical device, diagnostics, and pharmaceutical firms.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.